Skip to content

Anisha Memdani, MD

NPI 1790475945ActiveIndividual· Internal Medicine, Rheumatology· Salt Lake City, UT

Internal Medicine, Rheumatology (MD) in Salt Lake City, Utah, licensed in UT, with an NPI issued in May 2023. Part D covered 250 prescriptions written in 2024, 87% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $223.98 in all, mostly food and beverage.

Overview

NPI1790475945
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 10, 2023
Last updated in NPPESJul 24, 2026
Certified by providerJul 24, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (LA)

Part D prescriptions in 2024

Prescriptions (claims)250 · 424 30-day fills
Patients85
Total drug cost$25,075
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$223.98 · 2 payments from 2 companies
  • 2024$149.90 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$123.991
Sobi, Inc$99.991

What the 2025 payments were for

  • Food and Beverage$123.99 · 1 payment
  • Education$99.99 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other rheumatologists in Salt Lake City

All 28 rheumatologists in Salt Lake City · All rheumatologists in Utah